Takeda Pharmaceutical
316 hedge funds and large institutions have $2.45B invested in Takeda Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 100 increasing their positions, 98 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
9% less funds holding
Funds holding: 346 → 316 (-30)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
46% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 61
Holders
316
Holding in Top 10
5
Calls
$78.2M
Puts
$81.2M
Top Buyers
| 1 | +$26.4M | |
| 2 | +$20.2M | |
| 3 | +$18.2M | |
| 4 |
GCM
Glenview Capital Management
New York
|
+$17.4M |
| 5 |
Renaissance Technologies
New York
|
+$16M |
Top Sellers
| 1 | -$36.2M | |
| 2 | -$34.6M | |
| 3 | -$26.1M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$15.8M |
| 5 |
Morgan Stanley
New York
|
-$15.2M |